Ensign Peak Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $490K | Hold |
|
|||||
|
2025
Q1 | $437K | Buy |
|
|||||
|
2024
Q4 | $592K | Hold |
|
|||||
|
2024
Q3 | $796K | Hold |
|
|||||
|
2024
Q2 | $867K | Sell |
|
|||||
|
2024
Q1 | $7.49M | Sell |
|
|||||
|
2023
Q4 | $7.12M | Buy |
|
|||||
|
2023
Q3 | $2.54M | Hold |
|
|||||
|
2023
Q2 | $3.13M | Hold |
|
|||||
|
2023
Q1 | $3.31M | Hold |
|
|||||
|
2022
Q4 | $4.11M | Buy |
|
|||||
|
2022
Q3 | $301K | Hold |
|
|||||
|
2022
Q2 | $289K | Hold |
|
|||||
|
2022
Q1 | $365K | Hold |
|
|||||
|
2021
Q4 | $414K | Buy |
|